Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma

BACKGROUND: The concordance between mutations detected from plasma and tissue is critical for treatment choices of patients with advanced lung adenocarcinoma. METHODS: We prospectively analyzed the association of the serum tumor markers with the concordance between blood and tissue genomic profiles...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Xiao-Dong, Ding, Li-Ren, Zhang, Chuan-Tao, Qin, Bao-Dong, Liu, Ke, Jiang, Lian-Ping, Wang, Xi, Lv, Li-Ting, Ding, Hao, Li, Dao-Ming, Yang, Hui, Chen, Xue-Qin, Zhu, Wen-Yu, Wu, Ying, Ling, Yan, He, Xi, Liu, Jun, Shao, Lin, Wang, Hao-Zhe, Chen, Yan, Zheng, Jing-Jing, Inui, Naoki, Zang, Yuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350084/
https://www.ncbi.nlm.nih.gov/pubmed/34430361
http://dx.doi.org/10.21037/tlcr-21-543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350084/
https://www.ncbi.nlm.nih.gov/pubmed/34430361
http://dx.doi.org/10.21037/tlcr-21-543

Ejemplares similares